Royal Society of Chemistry, RSC Medicinal Chemistry, 12(13), p. 1621-1633, 2022
DOI: 10.1039/d2md00194b
Full text: Unavailable
Our understanding about the mode of action of pyrrolobenzodiazepine (PBD) monomers remains incomplete. This study reveals the DNA damaging potential of PBD monomers in bacteria, and identifies mechanisms involved in repair of these PBD-adducts.